Artivion Share Price Today
(NASDAQ: AORT)

Name: Artivion Share Price Today (NASDAQ: AORT) - Artivion Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Artivion share price is $25.37 & ₹2,206.40 as on 6 Mar 2025, 2.30 'hrs' IST

$25.37

▲

0.29

(1.16%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Artivion share price in Dollar and Rupees. Guide to invest in Artivion stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Artivion, along with analyst recommendations, forecasts, and comprehensive financials.

Artivion share price movements

Today's Low: $24.97
Today's High: $25.84
$25.37
1.58%
Downside
Day's Volatility :3.37%
Upside
1.82%
52 Weeks Low: $18.56
52 Weeks High: $32.33
$25.37
26.84%
Downside
52 Weeks Volatility :42.59%
Upside
21.53%

Artivion (AORT) Returns

Period	Artivion Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-13.94%	3.7%	0.0%
6 Months	-0.94%	-2.8%	0.0%
1 Year	32.41%	2.5%	0.0%
3 Years	19.05%	12.9%	-11.6%

Artivion (AORT) Key Statistics

in dollars & INR

Previous Close	$25.08
Open	$25.0
Today's High	$25.84
Today's Low	$24.97
Market Capitalization	$1.1B
Today's Volume	$384.5K
52 Week High	$32.33
52 Week Low	$18.5601
Revenue TTM	$388.5M
EBITDA	$52.2M
Earnings Per Share (EPS)	$-0.32
Profit Margin	-3.44%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-4.79%

How to invest in Artivion Stock (AORT) from India?

It is very easy for Indian residents to invest directly in Artivion from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Artivion stock in both Indian Rupees (INR) and US Dollars (USD). Search for Artivion or AORT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Artivion or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Artivion shares which would translate to 0.034 fractional shares of Artivion as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Artivion, in just a few clicks!

Returns in Artivion (AORT) for Indian investors in Rupees

The Artivion stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Artivion investment value today

Current value as on today

₹1,37,360

Returns

₹37,360

(+37.36%)

Returns from Artivion Stock

₹32,411 (+32.41%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Artivion (AORT)

-7%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Artivion Stock from India on INDmoney has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Artivion

BlackRock Inc
15.34%
Vanguard Group Inc
6.69%
Perceptive Advisors LLC
6.66%
Macquarie Group Ltd
6.53%
Morgan Stanley - Brokerage Accounts
5.63%
Juniper Investment Co, LLC
5.00%

Analyst Recommendation on Artivion

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Artivion(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Artivion Stock (AORT)

What analysts predicted

Upside of 27.45%

Target:

$32.33

Current:

$25.37

Insights on Artivion Stock (Ticker Symbol: AORT)

Price Movement
In the last 1 month, AORT stock has moved down by -18.9%
Increasing Revenue
Revenue is up for the last 2 quarters, 95.77M → 97.30M (in $), with an average increase of 1.6% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, 7.53M → -16.48M (in $), with an average decrease of 252.2% per quarter
AORT vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 55.3% return, outperforming this stock by 22.9%
AORT vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 138.2% return, outperforming this stock by 121.2%
Price to Sales
ForAORT every $1 of sales, investors are willing to pay $2.7, whereas for Boston Scientific Corp., the investors are paying $9.2 for every $1 of sales.

AORT Artivion Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$276.2M	↑ 5.09%
Net Income	$1.7M	↓ 145.2%
Net Profit Margin	0.62%	↑ 2.07%

	FY20	Y/Y Change
Revenue	$253.2M	↓ 8.32%
Net Income	$-16.7M	↓ 1069.88%
Net Profit Margin	-6.59%	↓ 7.21%

	FY21	Y/Y Change
Revenue	$298.8M	↑ 18.01%
Net Income	$-14.8M	↓ 11.08%
Net Profit Margin	-4.96%	↑ 1.63%

	FY22	Y/Y Change
Revenue	$313.8M	↑ 5.0%
Net Income	$-19.2M	↑ 29.38%
Net Profit Margin	-6.12%	↓ 1.16%

	FY23	Y/Y Change
Revenue	$354.0M	↑ 12.82%
Net Income	$-30.7M	↑ 59.91%
Net Profit Margin	-8.67%	↓ 2.55%

	FY24	Y/Y Change
Revenue	$388.5M	↑ 9.75%
Net Income	$-13.4M	↓ 56.47%
Net Profit Margin	-3.44%	↑ 5.23%

	Q3 FY23	Q/Q Change
Revenue	$87.9M	↓ 1.57%
Net Income	$-9.8M	↑ 189.8%
Net Profit Margin	-11.16%	↓ 7.37%

	Q4 FY23	Q/Q Change
Revenue	$93.7M	↑ 6.62%
Net Income	$-4.0M	↓ 59.44%
Net Profit Margin	-4.24%	↑ 6.92%

	Q1 FY24	Q/Q Change
Revenue	$97.4M	↑ 4.02%
Net Income	$7.5M	↓ 289.51%
Net Profit Margin	7.73%	↑ 11.97%

	Q2 FY24	Q/Q Change
Revenue	$98.0M	↑ 0.6%
Net Income	$-2.1M	↓ 128.1%
Net Profit Margin	-2.16%	↓ 9.89%

	Q3 FY24	Q/Q Change
Revenue	$95.8M	↓ 2.29%
Net Income	$-2.3M	↑ 8.08%
Net Profit Margin	-2.39%	↓ 0.23%

	Q4 FY24	Q/Q Change
Revenue	$97.3M	↑ 1.6%
Net Income	$-16.5M	↑ 620.41%
Net Profit Margin	-16.94%	↓ 14.55%

	FY19	Y/Y Change
Profit	$183.0M	↑ 5.8%

	FY20	Y/Y Change
Profit	$167.8M	↓ 8.32%

	FY21	Y/Y Change
Profit	$197.5M	↑ 17.72%

	FY22	Y/Y Change
Profit	$202.5M	↑ 2.54%

	FY23	Y/Y Change
Profit	$229.2M	↑ 13.16%

	FY24	Y/Y Change
Profit	$248.8M	↑ 8.55%

	Q3 FY23	Q/Q Change
Profit	$56.3M	↓ 3.12%

	Q4 FY23	Q/Q Change
Profit	$61.1M	↑ 8.57%

	Q1 FY24	Q/Q Change
Profit	$59.1M	↓ 3.3%

	Q2 FY24	Q/Q Change
Profit	$59.4M	↑ 0.49%

	Q3 FY24	Q/Q Change
Profit	$61.0M	↑ 2.76%

	Q4 FY24	Q/Q Change
Profit	$61.5M	↑ 0.81%

	FY19	Y/Y Change
Operating Cash Flow	$15.8M	↑ 60.18%
Investing Cash Flow	$-23.9M	↑ 256.56%
Financing Cash Flow	$-1.5M	↓ 41.73%

	FY20	Y/Y Change
Operating Cash Flow	$12.4M	↓ 21.85%
Investing Cash Flow	$-73.1M	↑ 205.43%
Financing Cash Flow	$93.6M	↓ 6369.79%

	FY21	Y/Y Change
Operating Cash Flow	$-2.6M	↓ 120.9%
Investing Cash Flow	$5.7M	↓ 107.74%
Financing Cash Flow	$-12.2M	↓ 113.06%

	FY22	Y/Y Change
Operating Cash Flow	$-5.2M	↑ 99.34%
Investing Cash Flow	$-10.7M	↓ 289.31%
Financing Cash Flow	$-1.6M	↓ 86.59%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$7.2M	↑ 4.68%
Investing Cash Flow	$-2.1M	↓ 129.22%
Financing Cash Flow	$-909.0K	↓ 140.71%

Artivion Technicals Summary

Sell

Neutral

Buy

Artivion is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Artivion (AORT) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Artivion Inc	-18.13%	-0.94%	32.41%	19.05%	3.05%
Medtronic Plc	3.4%	5.22%	9.95%	-11.8%	1.8%
Edwards Lifesciences Corp.	2.13%	10.35%	-17.53%	-32.76%	14.39%
Boston Scientific Corp.	1.13%	28.68%	55.31%	146.09%	207.16%
Stryker Corporation	0.84%	10.53%	11.46%	56.15%	129.21%
Abbott Laboratories	6.67%	21.76%	15.39%	15.86%	78.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Artivion Inc	NA	NA	181.5	0.58	-0.05	0.02	NA	6.59
Medtronic Plc	28.71	28.71	1.91	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	31.13	31.13	5.57	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	84.24	84.24	1.87	2.86	0.09	0.05	NA	14.76
Stryker Corporation	50.77	50.77	2.91	13.49	0.15	0.07	0.01	54.1
Abbott Laboratories	18.34	18.34	2.52	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Artivion Inc	Buy	$1.1B	3.05%	NA	-3.44%
Medtronic Plc	Buy	$119.3B	1.8%	28.71	12.83%
Edwards Lifesciences Corp.	Buy	$42.8B	14.39%	31.13	76.75%
Boston Scientific Corp.	Buy	$152.9B	207.16%	84.24	11.07%
Stryker Corporation	Buy	$148.8B	129.21%	50.77	13.25%
Abbott Laboratories	Buy	$238.6B	78.8%	18.34	31.95%

About Artivion

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

Organization	Artivion
Employees	0
CEO	Mr. James Patrick Mackin
Industry	Healthcare

Management People of Artivion

Name	Title
Mr. James Patrick Mackin	Chairman, President & CEO
Ms. Jean F. Holloway Esq.	Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary
Mr. John E. Davis	Senior VP & Chief Commercial Officer

Important FAQs about investing in AORT Stock from India :

What is Artivion share price today?

Artivion share price today stands at $25.37, Open: $25.00 ; Previous Close: $25.08 ; High: $25.84 ; Low: $24.97 ; 52 Week High: $32.33 ; 52 Week Low: $18.56.

The stock opens at $25.00, after a previous close of $25.08. The stock reached a daily high of $25.84 and a low of $24.97, with a 52-week high of $32.33 and a 52-week low of $18.56.

Can Indians buy Artivion shares?

Yes, Indians can invest in the Artivion (AORT) from India.

With INDmoney, you can buy Artivion at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Artivion at zero transaction cost.

How can I buy Artivion shares from India?

It is very easy to buy Artivion from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Artivion (AORT) be purchased?

Yes, you can buy fractional shares of Artivion with INDmoney app.

What are the documents required to start investing in Artivion stocks?

To start investing in Artivion, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.